Meet the Staff
Carole Samango-Sprouse, Ed.D.
Dr. Carole Samango-Sprouse (pictured here with a young patient) has been working with young disabled children since 1982. She received her doctorate in 1987 from The George Washington University, where she specialized in the neurodevelopmental assessment of children with complex medical conditions.
Dr. Samango-Sprouse is trained in neuromotor and neurocognitive development, neurobehavioral skills and oral motor assessment for children with an emphasis on young children with genetic disorders. She is trained in neurodevelopmental treatment (NDT) and certified in the assessment of pre-term infant behavior (APIB) and the Brazelton Neonatal Assessment Scale (BNABS). Dr. Samango-Sprouse studied neurobehavioral assessment with Dr. Heidilaise Als, a Harvard University professor and acclaimed developmental psychologist, at Children’s Hospital of Boston.
The author of more than 60 articles on the neurocognitive capabilities of atypical children, Dr. Samango-Sprouse studies the relationship between the brain and behavior, and its impact on school performance in children with neurogenetic disorders. Dr. Samango-Sprouse is an associate clinical professor of pediatrics at The George Washington University in Washington D.C.,
where she also serves on the medical staff at Children’s National Medical Center.
As the director of the Neurodevelopmental Diagnostic Center for Young Children, Dr. Samango-Sprouse evaluates patients from all over the world in order to develop comprehensive and intensive intervention programs that are syndrome-specific. These programs recognize the complex interaction and intimate connection between brain, cognition, behavior, learning, and medical diagnosis. Dr. Samango-Sprouse trains and educates parents and professionals around the country and internationally to understand the complex interaction between neurodevelopmental disorders, learning and educational success.
Dr. Samango-Sprouse believes that a family centered approach is necessary to optimize a child’s intellectual growth and develop appropriate intervention strategies in the home, school, and community. "Parents must be empowered with information about their child's medical condition, and how that condition will impact their child's learning and intellectual performance," says Dr. Samango-Sprouse. "When parents are armed with the right skills, they can advocate for a syndrome-specific educational program in order to optimize their child's educational program and development."
The uniqueness of the assessments performed by the Neurodevelopmental Center for Young Children is Dr. Samago-Sprouse’s expertise in the neurobehavioral and neurodevelopmental problems of children with neurogenetic and neurodevelopmental disorders. She is recognized internationally as an expert in X & Y Chromosomal Variations (often called Sex Chromosome Disorders or Sex Chromosome Variations), which involves a child having an extra X or Y chromosome in excess of the normal complement of 46XY for boys and 46XX for girls.
Through her practice, Dr. Samango-Sprouse serves one of the largest patient populations in the world of children who were prenatally diagnosed with an X & Y Chromosomal Variation. In addition, Dr. Samago-Sprouse is the founder, executive director and chief science officer of The Focus Foundation (www.thefocusfoundation.org), a not-for-profit organization created to help children overcome learning and chromosomal differences.
Dr. Samango-Sprouse is compiling a book about her experience working with “atypical learners.”
For more information about the book, or to share your family’s story, please contact Dr. Samango-Sprouse
Teresa Sadeghin, MS Ed., Program Manager
Teresa Sadeghin is the main contact for families served by the Neurodevelopmental Diagnostic Center for Young Children. She arranges appointments, coordinates studies, administers informed consents, organizes specialty programs, contacts and follows up with patients and parents. Mrs. Sadeghin
works closely with families to assist in implementing Dr. Samango-Sprouse's
targeted treatment programs.